Shanghai Henlius Biotech, Inc. (HKG: 2696)

Shanghai Henlius Biotech Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 14, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	10,951	7,555	6,957	11,984	25,517	22,147
Market Cap Growth	105.86%	8.59%	-41.95%	-53.04%	15.21%	-
Enterprise Value	14,592	11,112	10,233	13,635	25,011	22,671
Last Close Price	20.15	13.90	12.80	22.05	46.95	40.75
PE Ratio	14.77	12.62	-	-	-	-
Forward PE	17.01	12.55	-	-	-	-
PS Ratio	1.81	1.27	1.91	5.80	36.57	217.73
PB Ratio	3.95	3.13	3.76	4.25	6.72	4.95
P/TBV Ratio	-	-	-	25.87	12.46	5.50
P/FCF Ratio	16.20	11.94	15.51	-	-	-
P/OCF Ratio	11.96	6.54	6.27	108.01	-	-
EV/Sales Ratio	2.41	1.87	2.82	6.60	35.84	222.88
EV/EBITDA Ratio	11.71	11.07	-	-	-	-
EV/EBIT Ratio	17.06	15.97	-	-	-	-
EV/FCF Ratio	21.58	17.57	22.82	-	-	-
Debt / Equity Ratio	1.57	1.87	2.25	1.14	0.57	0.15
Debt / EBITDA Ratio	3.50	4.16	-	-	-	-
Debt / FCF Ratio	6.44	7.13	9.27	-	-	-
Asset Turnover	0.58	0.57	0.40	0.25	0.10	0.02
Inventory Turnover	1.90	1.95	1.43	1.44	0.84	0.93
Quick Ratio	0.30	0.34	0.27	0.35	0.67	2.46
Current Ratio	0.49	0.53	0.44	0.56	0.96	2.77
Return on Equity (ROE)	30.99%	28.52%	-35.35%	-35.81%	-27.60%	-30.17%
Return on Assets (ROA)	5.08%	4.19%	-4.88%	-6.11%	-9.37%	-11.25%
Return on Capital (ROIC)	7.99%	6.81%	-7.68%	-8.36%	-11.99%	-14.57%
Earnings Yield	5.99%	7.96%	-11.30%	-10.08%	-4.62%	-4.42%
FCF Yield	5.44%	8.37%	6.45%	-3.79%	-5.43%	-3.70%
Buyback Yield / Dilution	-0.11%	-0.25%	-0.59%	-1.75%	-6.52%	-16.54%
Total Shareholder Return	-0.11%	-0.25%	-0.59%	-1.75%	-6.52%	-16.54%

Source: S&P Capital IQ. Standard template. Financial Sources.